loading
Enliven Therapeutics Inc stock is traded at $20.52, with a volume of 208.83K. It is down -0.15% in the last 24 hours and up +6.88% over the past month. Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.
See More
Previous Close:
$20.55
Open:
$20.75
24h Volume:
208.83K
Relative Volume:
0.45
Market Cap:
$1.21B
Revenue:
-
Net Income/Loss:
$-85.21M
P/E Ratio:
-10.86
EPS:
-1.89
Net Cash Flow:
$-68.53M
1W Performance:
-4.16%
1M Performance:
+6.88%
6M Performance:
+12.13%
1Y Performance:
-29.19%
1-Day Range:
Value
$20.32
$20.81
1-Week Range:
Value
$20.10
$22.36
52-Week Range:
Value
$13.30
$29.79

Enliven Therapeutics Inc Stock (ELVN) Company Profile

Name
Name
Enliven Therapeutics Inc
Name
Phone
720-647-8519
Name
Address
6200 LOOKOUT ROAD, BOULDER
Name
Employee
63
Name
Twitter
Name
Next Earnings Date
2024-11-07
Name
Latest SEC Filings
Name
ELVN's Discussions on Twitter

Compare ELVN with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
ELVN
Enliven Therapeutics Inc
20.51 1.22B 0 -85.21M -68.53M -1.89
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
422.77 109.29B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
461.25 60.82B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
579.50 61.02B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
810.58 51.39B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ONC
Beone Medicines Ltd Adr
309.94 34.68B 4.56B -176.77M 225.30M -1.7177

Enliven Therapeutics Inc Stock (ELVN) Upgrades & Downgrades

Date Action Analyst Rating Change
Jun-16-25 Initiated Goldman Buy
Dec-13-24 Initiated BTIG Research Buy
Sep-09-24 Initiated H.C. Wainwright Buy
Jun-11-24 Initiated Robert W. Baird Outperform
Apr-09-24 Initiated Mizuho Buy
Mar-29-23 Initiated Jefferies Buy
View All

Enliven Therapeutics Inc Stock (ELVN) Latest News

pulisher
09:45 AM

Enliven Therapeutics Inc. recovery potential after sell offQuarterly Trade Summary & Daily Price Action Insights - newser.com

09:45 AM
pulisher
06:08 AM

Is Enliven Therapeutics Inc. stock positioned well for digital economyWeekly Trade Recap & Stepwise Entry and Exit Trade Signals - newser.com

06:08 AM
pulisher
05:54 AM

Applying sector rotation models to Enliven Therapeutics Inc.July 2025 Intraday Action & Free Fast Gain Swing Trade Alerts - newser.com

05:54 AM
pulisher
05:26 AM

Is Enliven Therapeutics Inc. stock a safe haven asset2025 Earnings Surprises & Community Consensus Trade Alerts - newser.com

05:26 AM
pulisher
01:37 AM

Why Enliven Therapeutics Inc. stock appeals to dividend seekersWeekly Profit Recap & Verified Trade Idea Suggestions - newser.com

01:37 AM
pulisher
Oct 23, 2025

Assessing Enliven Therapeutics (ELVN) Valuation as Shares Show Signs of Short-Term Momentum - Yahoo Finance

Oct 23, 2025
pulisher
Oct 23, 2025

Real time breakdown of Enliven Therapeutics Inc. stock performanceEarnings Trend Report & Weekly High Return Forecasts - newser.com

Oct 23, 2025
pulisher
Oct 23, 2025

Is Enliven Therapeutics Inc. stock cheap compared to fundamentalsFed Meeting & Target Return Focused Stock Picks - newser.com

Oct 23, 2025
pulisher
Oct 23, 2025

Enliven Therapeutics Insider Sold Shares Worth $276,025, According to a Recent SEC Filing - MarketScreener

Oct 23, 2025
pulisher
Oct 23, 2025

Published on: 2025-10-23 01:40:18 - newser.com

Oct 23, 2025
pulisher
Oct 22, 2025

Lyssikatos, chief scientific officer, sells Enliven Therapeutics shares By Investing.com - Investing.com Canada

Oct 22, 2025
pulisher
Oct 22, 2025

Brokerages Set Enliven Therapeutics, Inc. (NASDAQ:ELVN) Price Target at $41.20 - Defense World

Oct 22, 2025
pulisher
Oct 21, 2025

Enliven Therapeutics CEO Kintz sells $266k in shares By Investing.com - Investing.com UK

Oct 21, 2025
pulisher
Oct 21, 2025

ELVN insider sale: 12,500 shares sold; 902,892 shares remain held - Stock Titan

Oct 21, 2025
pulisher
Oct 21, 2025

Is now a turning point for Enliven Therapeutics Inc.Global Markets & Risk Controlled Daily Plans - newser.com

Oct 21, 2025
pulisher
Oct 21, 2025

Strategies to average down on Enliven Therapeutics Inc.Quarterly Profit Review & AI Powered Market Trend Analysis - newser.com

Oct 21, 2025
pulisher
Oct 21, 2025

How to read the order book for Enliven Therapeutics Inc.2025 Institutional Moves & Verified Entry Point Signals - newser.com

Oct 21, 2025
pulisher
Oct 20, 2025

Automated trading signals detected on Enliven Therapeutics Inc.Market Sentiment Report & Free Low Drawdown Momentum Trade Ideas - newser.com

Oct 20, 2025
pulisher
Oct 18, 2025

Trading Recap: Why retail investors favor Enliven Therapeutics Inc. stockEarnings Overview Summary & Verified Momentum Stock Watchlist - nchmf.gov.vn

Oct 18, 2025
pulisher
Oct 18, 2025

Will Enliven Therapeutics Inc. stock rally after Fed decisions2025 Key Lessons & Real-Time Chart Pattern Alerts - nchmf.gov.vn

Oct 18, 2025
pulisher
Oct 18, 2025

Will Enliven Therapeutics Inc. stock split again soon2025 Market WrapUp & Reliable Breakout Forecasts - nchmf.gov.vn

Oct 18, 2025
pulisher
Oct 18, 2025

Will Enliven Therapeutics Inc. stock outperform tech sector in 2025July 2025 Institutional & Pattern Based Trade Signal System - nchmf.gov.vn

Oct 18, 2025
pulisher
Oct 18, 2025

Heatmap analysis for Enliven Therapeutics Inc. and competitorsWatch List & Target Return Focused Picks - newser.com

Oct 18, 2025
pulisher
Oct 17, 2025

Why retail investors favor Enliven Therapeutics Inc. stockWeekly Loss Report & Daily Profit Focused Screening - nchmf.gov.vn

Oct 17, 2025
pulisher
Oct 17, 2025

Will Enliven Therapeutics Inc. stock continue dividend increases2025 Performance Recap & Daily Entry Point Trade Alerts - nchmf.gov.vn

Oct 17, 2025
pulisher
Oct 17, 2025

(ELVN) as a Liquidity Pulse for Institutional Tactics - news.stocktradersdaily.com

Oct 17, 2025
pulisher
Oct 17, 2025

Enliven Therapeutics, Inc. (ELVN) Stock Analysis: Investor Outlook on a Potential 89.66% Upside - DirectorsTalk Interviews

Oct 17, 2025
pulisher
Oct 16, 2025

Enliven Therapeutics (NASDAQ:ELVN) Trading 8.1% Higher – Time to Buy? - Defense World

Oct 16, 2025
pulisher
Oct 15, 2025

Tools to monitor Enliven Therapeutics Inc. recovery probabilityRecession Risk & Daily Profit Maximizing Tips - newser.com

Oct 15, 2025
pulisher
Oct 15, 2025

Published on: 2025-10-15 02:57:52 - newser.com

Oct 15, 2025
pulisher
Oct 14, 2025

What the charts say about Enliven Therapeutics Inc. todayShort Setup & Daily Volume Surge Trade Alerts - newser.com

Oct 14, 2025

Enliven Therapeutics Inc Stock (ELVN) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Enliven Therapeutics Inc Stock (ELVN) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Kintz Samuel
PRESIDENT AND CEO
Oct 17 '25
Sale
21.33
12,500
266,654
902,892
$37.21
price up icon 0.99%
$91.23
price up icon 2.16%
$29.75
price down icon 0.22%
$105.59
price up icon 0.69%
$160.60
price up icon 0.36%
biotechnology ONC
$309.94
price up icon 0.01%
Cap:     |  Volume (24h):